Search
for
Sort by
Research 151–180 of 493
- Hair and nail involvement in lupus erythematosus
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Kawasaki disease: an update
- The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey
- Skin diseases in consequence of endocrine alterations
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Dengue Virus Infects Primary Human Hair Follicle Dermal Papilla Cells
- Non-hemorrhage-related adverse effects of rivaroxaban
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Male fertility and skin diseases
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Psychoactive drugs and skin
- Clinical picture of infectious syphilis
- Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study
- Drug eruptions in dermatology
- “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome
- CUTANEOUS T-CELL LYMPHOMA
- Comparison of the Pathology of Fascia in Eosinophilic Myalgia Syndrome Patients and Idiopathic Eosinophilic Fasciitis
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Symptom management in inflammatory bowel disease
- Fixed-Drug Eruption due to Dextromethorphan
- Current concepts in the pathogenesis and treatment of acne
- Patient Use of Complementary and Alternative Medicine for Psoriasis Vulgaris and Factors Believed to Trigger the Disease: A Multicenter Cross-Sectional Study with 1621 Patients
- Drug safety evaluation of exemestane
- COVID‐19, androgens, and androgenic alopecia